Is monthly retreatment with intravitreal bevacizumab (Avastin&reg;) necessary in neovascular age-related macular degeneration?

QR Code

Is monthly retreatment with intravitreal bevacizumab (Avastin&reg;) necessary in neovascular age-related macular degeneration?

Nicola G Ghazi, Tyler Q Kirk, Robert M Knape, James S Tiedeman, Brian P ConwayDepartment of Ophthalmology, University of Virginia Health System, Charlottesville, VA, USAPurpose: To report our short-term experience with bevacizumab in neovascular age-related macular degeneration (AMD) and recommend a...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Nicola G Ghazi, Tyler Q Kirk, Robert M Knape, et al
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2010
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/8fcfeaad584e4ce9ab50cf2d60b2a22e
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The effect of intravitreal bevacizumab (Avastin&reg;) on ocular pulse amplitude in neovascular age-related macular degeneration
par: Ehud Rechtman, et autres
Publié: (2011)

Bevacizumab (Avastin&reg;) for the management of anterior chamber neovascularization and neovascular glaucoma
par: Dimitrios Brouzas, et autres
Publié: (2009)

Pharmacokinetics of intravitreal bevacizumab (Avastin&reg;) in rabbits
par: Sinapis C, et autres
Publié: (2011)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
par: Juan Carlos Mesa Guti&eacute;rrez, et autres
Publié: (2008)

Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin&reg;) for AMD followed by controlateral sympathetic ophthalmia
par: Dimitrios Brouzas, et autres
Publié: (2009)

Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
par: Mamdouh M Kabeel, et autres
Publié: (2008)

Intravitreal bevacizumab has initial clinical benefit lasting eight weeks in eyes with neovascular age-related macular degeneration
par: P William Conrad, et autres
Publié: (2008)

Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization
par: Ioannis D Ladas, et autres
Publié: (2008)

VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF BRANCH RETINAL VEIN OCCLUSION
par: Saquib Naeem, et autres
Publié: (2019)

Use of nepafenac (Nevanac&reg;) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections
par: Eric Chen, et autres
Publié: (2010)

Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab
par: Allegrini D, et autres
Publié: (2021)

Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
par: Palejwala NV, et autres
Publié: (2014)

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
par: Thapa R, et autres
Publié: (2012)

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
par: Demir M, et autres
Publié: (2011)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
par: Jia-Kang Wang, et autres
Publié: (2018)

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration
par: Roberto Gallego-Pinazo, et autres
Publié: (2011)

Histology of neovascular myopic macular degeneration
par: Shefali B. Jonas, et autres
Publié: (2021)

Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab
par: Neeraj Pandey, et autres
Publié: (2010)

Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
par: Marey HM, et autres
Publié: (2011)

Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
par: Elfandi S, et autres
Publié: (2021)

Lucentis&reg; using Visudyne&reg; study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration
par: Eric Chen, et autres
Publié: (2010)

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
par: Shakarchi FI, et autres
Publié: (2018)

Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization
par: Mansour AM, et autres
Publié: (2012)

Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma
par: Canut MI, et autres
Publié: (2011)

Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy
par: Grimelda Yuriana S&aacute;nchez-Castro, et autres
Publié: (2008)

Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma
par: Kubota-Taniai M, et autres
Publié: (2011)

Intravitreal bevacizumab injection and carotid artery stent replacement for neovascular glaucoma in internal carotid artery occlusion
par: Aya Kodama, et autres
Publié: (2010)

Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
par: Dimitrios A Karagiannis, et autres
Publié: (2009)

Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: a meta-analysis.
par: Wei Wang, et autres
Publié: (2014)

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
par: Jeon S, et autres
Publié: (2014)

Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion
par: Ito Y, et autres
Publié: (2015)

Successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye
par: Hahn P
Publié: (2014)

Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
par: Pukhraj Rishi, et autres
Publié: (2011)

Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections
par: Antaki F, et autres
Publié: (2021)

Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration
par: Luis Arias, et autres
Publié: (2010)

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema
par: O&#39;Day R, et autres
Publié: (2013)

Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathy
par: Hidetaka Matsumoto, et autres
Publié: (2021)

Radiation therapy for neovascular age-related macular degeneration
par: Robert Petrarca, et autres
Publié: (2011)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
par: Yalamanchi S, et autres
Publié: (2011)

Proteins from Avastin® (bevacizumab) show tyrosine nitrations for which the consequences are completely unclear.
par: Jia Wan, et autres
Publié: (2012)